drugset / Trial / NCT02464059
Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD
Phase 2
Completed
23 enrolled
University of North Carolina, Chapel Hill
Johns Hopkins University · collab
NaSingle-groupOpen-labelBasic science
Summary
This proposal will evaluate a potential mechanism of increased risk of lung function impairment, cathelicidin levels, as well as determine if vitamin D replacement can alter this pathway. This study will improve the understanding of factors which can lead to chronic lung disease. If effective, this application would also provide the justification to study vitamin D as a therapy to improve lung health.
Timeline
- Start
- 2015-11-10
- Primary completion
- 2020-04-15
- Completion
- 2020-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 50000 iu | Oral |